SCHEMBL21683322

SCHEMBL21683322

CC1(C)O[C@H]2CSC(CO)(CO)[C@H]2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15985091 0.66 LSS (0.31) —
SCHEMBL17360575 0.66 LSS (0.31) —
SCHEMBL17752946 0.66 LSS (0.31) —
SCHEMBL16062249 0.63 CA1 (0.34) —
SCHEMBL22640959 0.63 — —
SCHEMBL31186924 0.61 — —
SCHEMBL21685923 0.60 MGAM (0.33) —
SCHEMBL21683414 0.60 MGAM (0.33) —
SCHEMBL14296872 0.60 MGAM (0.33) —
SCHEMBL9884660 0.59 GLB1 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3833668-B1 PRMT5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-03-19 — — EP disclosed
US-11993602-B2 PRMT5 inhibitors MERCK SHARP & DOHME LLC (US) 2024-05-28 — — US disclosed
US-20210277009-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-09-09 — — US disclosed
US-20210277009-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2021-09-09 — — US disclosed
EP-3833668-A1 PRMT5 INHIBITORS Merck Sharp & Dohme Corp. (US) 2021-06-16 — — EP disclosed
WO-2020033282-A1 PRMT5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 — — WO disclosed
Send feedback